Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, marking it as the first treatment in the country authorised to assist in chronic weight management and to reduce the risk ...

Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover ...

Nov 27 (Reuters) - Canada's health regulator has approved Novo Nordisk's (NOVOb.CO), opens new tab weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in ...

Novo Nordisk (NVO) reported its newest GLP-1 product, CagriSema, provides an average of 22.7% weight loss, but that wasn't enough to convince investors, sparking a sell-off of the stock.

FRANKFURT, Germany — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the ...

You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk has signed another obesity pact, this one for an oral drug that works via an uncommon mechanism and could potentially help patients ...

Novo Nordisk A/S is prepared for potential tariffs ... Trump has threatened tariffs on key trading partners Canada, Mexico and China, which has left some manufacturing companies scrambling to ...

Lars Jørgensen, chief executive of the Ozempic manufacturer Novo Nordisk, defended the prices ... is sold for $59 in Germany and $155 in Canada, according to a HELP report released in April.

Senators grilled the top executive of Novo ... Nordisk's prices charged to Americans and Europeans. The company charges U.S. residents $969 a month for Ozempic, but the same drug costs $155 in ...